Previous authors have postulated by that there are both serotonin reuptake transporter SERT and serotonin dependant and independent effects of Fluoxetine on movement in C. elegans (Weinshenker, Garriga et al. 1995; Choy and Thomas 1999; Ranganathan, Sawin et al. 2001) . Of interest to this study is that
tph-1 (mg 280) remain wholly susceptible to fluoxetine induced paralysis indicating alternative targets at the neuromuscular junction. We show that both fluoxetine and serotonin cause wild-type C. elegans to become immobile by relaxation of the body wall muscles. Although short-term exposure to exogenous serotonin does cause immobility, animals eventually become desensitized or adapted and they start moving; fluoxetine treated animals do not adapt and remain paralysed. Exogenous serotonin can rescue immobility caused by chronic fluoxetine exposure implying that the drug could be competing with endogenous serotonin for common binding sites to regulate both serotonin signalling and locomotion. Consistent with this notion animals lacking (
tph-1 ) or with reduced serotonin (
unc-86;
nss-1 mutants) may be more susceptible to paralysis by fluoxetine as they possess no or less endogenous serotonin to compete with fluoxetine for binding sites . Serotonin has been proposed to inhibit cholinergic signalling via the regulatory protein EAT-16 at the neuromuscular junction (Hajdu-Cronin, Chen et al. 1999) . Similar to the action of serotonin, fluoxetine can suppress the expression of a reporter for acetylcholine biosysnthesis (
cha-1::gfp ) . Mutants lacking the nicotinic and muscarinic signalling components (
unc-29 ,
egl-8 and
egl-30 ) are all more susceptible to paralysis by fluoxetine. Fluoxetine may persistently down-regulate acetylcholine production and block signalling via cholinergic receptors to immobilise C. elegans. Choy, R. K. M. and J. H. Thomas (1999). "Fluoxetine-resistant mutants in C-elegans define a novel family of transmembrane proteins." Molecular Cell 4 (2): 143-152. Hajdu-Cronin, Y. M., W. J. Chen, et al. (1999). "Antagonism between G(o)alpha and G(q)alpha in Caenorhabditis elegans: the RGS protein EAT-16 is necessary for G(o)alpha signaling and regulates G(q)alpha activity." Genes & Development 13 (14): 1780-1793. Ranganathan, R., E. R. Sawin, et al. (2001). "Mutations in the Caenorhabditis elegans serotonin reuptake transporter MOD-5 reveal serotonin-dependent and -independent activities of fluoxetine." Journal of Neuroscience 21 (16): 5871-5884. Weinshenker, D., G. Garriga, et al. (1995). "Genetic and Pharmacological Analysis of Neurotransmitters Controlling Egg-Laying in C-Elegans." Journal of Neuroscience 15 (10): 6975-6985.